clinical research on siddha medicine Gendhaga Vallaathi in the treatment of Uthira Vaatha Suronitham(Rheumatoid Arthritis)
- Conditions
- Health Condition 1: null- UTHIRA VAATHA SURONITHAM (Rheumatoid arthritis)
- Registration Number
- CTRI/2014/11/005180
- Lead Sponsor
- AYOTHIDOSS PANDITHAR HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 40
1) Guidelines for classification :
a. 4 of 7 criteria are required to classify a patient as having RA
b. Patients with 2 or more clinical diagnosis are not excluded
3) Criteria : Morning stiffness: stiffness in and around the joints lasting 1 hr before maximal improvement.
2) Arthritis of 3 or more joint areas: Atleast 3 joints areas , have soft tissue swellings or joint effusions not just bony overgrowth.The 14 possible joints areas involved are right or left proximal interphalangeal joint,metacarpophalangealjoint,wrist,elbow,knee,ankle, metatarsophalangeal joint
3) Symmetrical arthritis
4) Arthritis of hand joints-these should be atleast 6 weeks
5) Rheumatoid factor positive
6) Rheumatoid nodules [21]
7) Anti â?? CCP positive
8) Patients who had the pain score of 0 to 6.
9) Patients willing for admission and stay in IPD or willing to attend OPD
10)Patient willing to undergo Radiological investigation and provide blood and urine for laboratory investigation.
11) Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment during 48 days but can opt out of the trial of his/her own conscious discretion.
•Diabetes Mellitus
•Hypertension
•Pregnancy and lactation
•Any other serious systemic illness
•Drug Addicts
•SLE
•H/O undergone DMARDs (past 3 month)
•Patients who had the pain score of 7 to 10
•Osteoarthritis
•Tubercular Arthritis
•Gouty Arthritis
•Psoriatic Arthritis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is mainly assessed by UNIVERSAL PAIN ASSESSMENT SCALE- Numeric Rating Scale before and after treatment. <br/ ><br> <br/ ><br>UNIVERSAL PAIN ASSESMENT SCALE: <br/ ><br> Grade 0 : No Pain <br/ ><br> Grade 1 -3 : Mild pain <br/ ><br> Grade 4-6 : Moderate pain <br/ ><br> Grade 7-10: Severe pain <br/ ><br>Timepoint: PRE STUDY SCREENING AND AFTER TREATMENT
- Secondary Outcome Measures
Name Time Method It is assessed by the following parameters before and after treatment. <br/ ><br>1.Reduction in clinical symptoms <br/ ><br>2.Health Assessment Questionnarie [20] <br/ ><br>3.Hb and ESR variations. <br/ ><br>4.RA and CRP variations <br/ ><br>Timepoint: PRE STUDY SCREENING AND AFTER TREATMENT